Nuclear Medicine Market | USD 7.22 Bn. in 2023 - Growth Prospects with Jubilant Lifesciences, Mallinckrodt Pharmaceuticals
Nuclear Medicine Market Expected to Reach $18.87 Billion by 2030, Driven by Growing Demand for Diagnosis and Treatment of Chronic Diseases
Market Overview:
The global nuclear medicine market is poised to reach $18.87 billion by 2030, expanding at a CAGR of 14.7% from 2024. This growth is fueled by the rising prevalence of chronic diseases like cancer and cardiovascular disorders, increasing adoption of advanced imaging technologies, and the growing geriatric population.
To get the sample please click here: https://www.maximizemarketresearch.com/request-sample/98418
Report Scope:
This comprehensive report offers insights into the global nuclear medicine market, covering:
Market size and growth forecasts from 2023 to 2030
Segmentation by product type (diagnostic, therapeutic), application (neurology, oncology, cardiology, others), modality (SPECT, PET, alpha-emitters, beta-emitters, brachytherapy), procedure (oncology, cardiovascular, etc.), and end-user (hospitals, laboratories, etc.)
Competitive landscape
Key drivers, restraints, opportunities, and challenges
Research Methodology:
A meticulous research approach was employed to ensure an in-depth analysis of the market landscape, utilizing:
Primary data: Surveys, interviews, and interactions with industry experts
Secondary data: Research reports, company filings, government statistics, and industry publications
Segmentation:
Product Type: The diagnostic segment holds the largest market share due to its wide range of applications in various medical specialties.
Application: The oncology segment is expected to witness the fastest growth due to the increasing incidence of cancer and the growing adoption of nuclear medicine for diagnosis and treatment.
Region: North America is expected to remain the dominant market throughout the forecast period due to the high volume of nuclear medicine procedures, well-developed healthcare infrastructure, and significant R&D investments.
Regional Insights:
North America: Holds the largest market share and is projected to maintain its lead due to advanced healthcare infrastructure and high adoption rates.
Europe: Strong presence of established players and growing focus on personalized medicine are driving growth.
Asia Pacific: Rapidly growing healthcare sector, increasing disposable income, and government initiatives are propelling market expansion.
Latin America and Middle East & Africa: Emerging markets with immense potential due to the rising demand for advanced healthcare solutions and increasing government support.
Nuclear Medicine Market, Key Players are:
1. Cardinal Health Inc (US)
2. GE HealthCare Technologies Inc (US)
3. Jubliant Lifesciences (US)
4. Lantheus Medical Imaging Inc. (US)
5. Biodex Medical Systems, Inc. (US)
6. Standard Imaging Inc. (US)
7. Digirad Corporation (US)
8. CMR Naviscan (US)
9. Nordion Inc. (Canada)
10. Bayer AG (Germany)
11. Siemens Healthineers (Germany)
12. SurgicEye GmbH (Germany)
13. Curium (France)
14. Advanced Accelerator Applications (France)
15. Mallinckrodt Pharmaceuticals (UK)
16. Bartec Technologies Ltd. (UK)
17. Norgine B.V. (Netherland)
18. Medtronic plc (Ireland)
19. DDD-Diagnostic A/S (Denmark)
20. Mediso Ltd. (Hungary)
21. Neusoft Corporation (China)
22. Canon Medical Systems Corporation (Japan)
23. FUJIFILM Holdings Corporation (Japan)
24. Cyclopharm (Australia)
25. Bozlu Holding A.Ş (Turkey)
Conclusion:
The nuclear medicine market presents significant growth opportunities due to the increasing demand for accurate and effective diagnosis and treatment of chronic diseases. Advancements in technology, rising healthcare awareness, and increasing government support in developing regions are expected to further drive market expansion in the coming years.
To gain deeper insights into the market analysis, explore the summary of the research report: https://www.maximizemarketresearch.com/market-report/global-nuclear-medicine-market/98418/
About Maximize Market Research:
Maximize Market Research distinguishes itself through its steadfast dedication to excellence and innovation, led by a team of seasoned professionals with extensive industry expertise. Our capabilities encompass meticulously researched insights, comprehensive technological analyses, and strategic guidance derived from thorough evaluations of competitive landscapes. Rooted in adaptability and innovation, we serve as a guiding light at the forefront of industry trends. Our commitment is dynamic, constantly evolving to meet the unique and evolving needs of our clients, ensuring that our services remain cutting-edge in an ever-changing business environment. This dedication positions us as trailblazers, adeptly navigating clients through the challenges of a dynamic market and reinforcing our leadership position. Our primary focus is on driving clients' success by delivering unparalleled value, anticipating market shifts and trends, and nurturing long-term partnerships. We strive to be more than mere service providers but trusted allies, supporting our clients' journey towards sustained success in the dynamic business landscape.
Contact Maximize Market Research:
MAXIMIZE MARKET RESEARCH PVT. LTD.
⮝ 3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
✆ +91 9607365656
🖂 sales@maximizemarketresearch.com
🌐 www.maximizemarketresearch.com
More Related Report:
Customer Journey Analytics Market https://www.maximizemarketresearch.com/market-report/global-customer-journey-analytics-market/6437/
Critical Communication Market https://www.maximizemarketresearch.com/market-report/global-critical-communication-market/36320/
Railway System Market https://www.maximizemarketresearch.com/market-report/railway-system-market/183999/